申请人:Boehringer Ingelheim Pharma KG
公开号:US20030130265A1
公开(公告)日:2003-07-10
The invention concerns benzimidazole derivatives of the general formula (I)
1
in which the radicals R
1
, R
2
, R
3
, X
1
and A can have the meanings assigned to them in the specification, their prodrugs, processes for their production as well as the use of the benzimidazole derivatives as medicines, especially as medicines that have trypsin-inhibiting action.
这项发明涉及通式(I)的苯并咪唑衍生物
1
其中基团R
1
,R
2
,R
3
,X
1
和A可以在规范中分配给它们的含义,它们的前药,其生产过程以及将苯并咪唑衍生物用作药物,特别是用作具有胰蛋白酶抑制作用的药物。